Labs Pushed for 'Clean Claims'
To ensure accurate payments and PAMA compliance, labs are being advised to strengthen their front-end RCM processes. HealthRecon Connect recommends focusing on documentation, coding, and claim validation through pre-submission audits and payer-specific edits to achieve 'clean claims' on the first attempt.
The Protecting Access to Medicare Act (PAMA) of 2014 fundamentally changed how Medicare reimburses for clinical lab tests, shifting to a system based on private payer rates. This resulted in significant reimbursement cuts, with some common tests seeing reductions of up to 30% over three years. These cuts have been particularly damaging for labs serving rural and underserved communities. The initial data collection process under PAMA was flawed, overrepresenting large independent labs and under-sampling hospital and physician office labs. This skewed data led to nearly $4 billion in cuts and prompted multiple legislative delays to prevent further reductions. The next round of potential cuts has been postponed, with a new data collection period scheduled for the first half of 2025 to set 2027 rates. A "clean claim" is a medical claim submitted to a payer without any errors or omissions, allowing for prompt processing and payment, often within 45 days. Achieving a high clean claim rate, ideally 95% or better, is critical for accelerating revenue cycles and reducing the administrative burden of rework. Roughly one in five medical claims are denied on the first submission. Common reasons for denial in laboratory claims include missing or incorrect patient information, coding errors, lack of medical necessity documentation, and issues with prior authorization. Front-end Revenue Cycle Management (RCM) processes are the first line of defense against claim denials. Key front-end functions include patient registration, insurance eligibility verification, charge capture, and medical coding. Automating and optimizing these initial steps is essential to prevent errors that lead to delayed or lost revenue. Legislation like the Saving Access to Laboratory Services (SALSA) Act and the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act have been introduced to address PAMA's flaws. These proposals aim to create a more representative data collection method and stabilize reimbursement rates for clinical laboratories.
